|
[1]
|
Hyman, A.S. (1932) Resuscitation of the Stopped Heart by Intracardial Therapy. II. Experimental Use of an Artificial Pacemaker. Archives of Internal Medicine, 50, 283-305. [Google Scholar] [CrossRef]
|
|
[2]
|
Elmqvist, R. and Senning, A. (1960) Implantable Pacemaker for the Heart. In: Smyth, C.N., Ed., Medical Electronics, Proceedings of the Second International Conference on Medical Electronics, Iliffe and Sons, London, 253-254.
|
|
[3]
|
Epstein, A.E., et al. (2008) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) De-veloped in Collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Journal of the American College of Cardiology, 51, e1-e62.
|
|
[4]
|
Deharo, J.C., et al. (2012) Pathways for Training and Accreditation for Transvenous Lead Extraction: A European Heart Rhythm Association Position Paper. Europace, 14, 124-134. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Noseworthy, P.A., et al. (2019) Subclinical and De-vice-Detected Atrial Fibrillation: Pondering the Knowledge Gap: A Scientific Statement From the American Heart Association. Circulation, 140, e944-e963. [Google Scholar] [CrossRef]
|
|
[6]
|
Chen-Scarabelli, C., et al. (2015) Device-Detected Atrial Fibrillation: What to Do with Asymptomatic Patients? Journal of the American College of Cardiology, 65, 281-294. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Purerfellner, H., et al. (2004) Accuracy of Atrial Tachyarrhythmia Detection in Implantable Devices with Arrhythmia Therapies. Pacing and Clinical Electrophysiology, 27, 983-992. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Plummer, C.J. and McComb, J.M. (2003) Detection of Atrial Fibrillation by Permanent Pacemakers: Observations from the STOP AF Trial. Cardiac Electrophysiology Review, 7, 333-340. [Google Scholar] [CrossRef]
|
|
[9]
|
Healey, J.S., et al. (2012) Subclinical Atrial Fibrilla-tion and the Risk of Stroke. The New England Journal of Medicine, 366, 120-129. [Google Scholar] [CrossRef]
|
|
[10]
|
Kaufman, E.S., et al. (2012) Positive Predictive Value of De-vice-Detected Atrial High-Rate Episodes at Different Rates and Durations: An Analysis from ASSERT. Heart Rhythm Journal, 9, 1241-1246. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Mahajan, R., et al. (2018) Subclinical Device-Detected Atrial Fibrillation and Stroke Risk: A Systematic Review and Meta-Analysis. European Heart Journal, 39, 1407-1415. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Boriani, G., et al. (2018) Detection of New Atrial Fibrillation in Patients with Cardiac Implanted Electronic Devices and Factors Associated with Transition to Higher Device-Detected Atrial Fibrillation Burden. Heart Rhythm Journal, 15, 376-383. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Ziegler, P.D., et al. (2010) Incidence of Newly Detected Atrial Arrhythmias via Implantable Devices in Patients with a History of Thromboembolic Events. Stroke, 41, 256-260. [Google Scholar] [CrossRef]
|
|
[14]
|
Cheung, J.W., et al. (2006) Newly Detected Atrial Fi-brillation Following Dual Chamber Pacemaker Implantation. Journal of Cardiovascular Electrophysiology, 17, 1323-1328. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Witt, C.T., et al. (2015) Early Detection of Atrial High Rate Episodes Predicts Atrial Fibrillation and Thromboembolic Events in Patients with Cardiac Resyn-chronization Therapy. Heart Rhythm Journal, 12, 2368-2375. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Ogino, Y., et al. (2017) Characteristics and Prognosis of Pace-maker-Identified New-Onset Atrial Fibrillation in Japanese People. Circulation Journal, 81, 794-798. [Google Scholar] [CrossRef]
|
|
[17]
|
Sade, L.E., et al. (2016) Determinants of New-Onset Atrial Fibril-lation in Patients Receiving CRT: Mechanistic Insights From Speckle Tracking Imaging. JACC: Cardiovascular Imaging, 9, 99-111. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Xing, F., et al. (2018) Association between Paced QRS Duration and Atrial Fibrillation after Permanent Pacemaker Implantation: A Retrospective Observational Cohort Study. Medicine, 97, e9839. [Google Scholar] [CrossRef]
|
|
[19]
|
Kim, B.S., et al. (2016) Predictors and Long-Term Clinical Outcomes of Newly Developed Atrial Fibrillation in Patients with Cardiac Implantable Electronic Devices. Medicine, 95, e4181. [Google Scholar] [CrossRef]
|
|
[20]
|
Israel, C., et al. (2017) Detection of Atrial Fibrillation in Patients with Embolic Stroke of Undetermined Source by Prolonged Monitoring with Implantable Loop Recorders. Thrombosis and Haemostasis, 117, 1962-1969. [Google Scholar] [CrossRef]
|
|
[21]
|
Nishinarita, R., et al. (2019) Burden of Implanted-Device-Detected Atrial High-Rate Episode Is Associated with Future Heart Failure Events-Clinical Significance of Asymptomatic Atrial Fibrillation in Patients with Implantable Cardiac Electronic Devices. Circulation Journal, 83, 736-742. [Google Scholar] [CrossRef]
|
|
[22]
|
Mazza, A., et al. (2019) Occurrence of Atrial Fibrillation in Pace-maker Patients and Its Association with Sleep Apnea and Heart Rate Variability. European Journal of Internal Medicine, 68, 13-17. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Heijman, J., et al. (2016) The Value of Basic Research Insights into Atrial Fibrillation Mechanisms as a Guide to Therapeutic Innovation: A Critical Analysis. Cardiovascular Research, 109, 467-479. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Chen, P.S., et al. (2014) Role of the Autonomic Nervous System in Atrial Fibrillation: Pathophysiology and Therapy. Circulation Research, 114, 1500-1515. [Google Scholar] [CrossRef]
|
|
[25]
|
Shi, Y., et al. (2001) Remodeling of Atrial Dimensions and Emptying Function in Canine Models of Atrial Fibrillation. Cardiovascular Research, 52, 217-225. [Google Scholar] [CrossRef]
|
|
[26]
|
De Jong, A.M., et al. (2011) Mechanisms of Atrial Structural Changes Caused by Stretch Occurring before and during Early Atrial Fibrillation. Cardiovascular Research, 89, 754-765. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Said, S., et al. (2014) Incidence of New Onset Atrial Fibrillation in Patients with Permanent Pacemakers and the Relation to the Pacing Mode. Medical Science Monitor, 20, 268-273. [Google Scholar] [CrossRef]
|
|
[28]
|
Barold, S.S. and Stroobandt, R.X. (2012) Pacemaker-Mediated Tachycardia Initiated by an Atrioventricular Search Algorithm to Minimize Right Ventricular Pacing. Journal of Electrocardiology, 45, 336-339. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Martins, R.P., et al. (2016) Atrial Fibrillation in a Du-al-Chamber ICD Recipient with Activation of the Ventricular Intrinsic Preference Algorithm: What Is the Mechanism? Pacing and Clinical Electrophysiology, 39, 880-882. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Kirchhof, P. (2017) The Future of Atrial Fibrillation Management: Inte-grated Care and Stratified Therapy. The Lancet, 390, 1873-1887. [Google Scholar] [CrossRef]
|
|
[31]
|
Wang, T.Y. (2019) Effectively Initiating and Maintaining Anticoagulation in Patients with Atrial Fibrillation. Circulation, 139, 1763-1765. [Google Scholar] [CrossRef]
|
|
[32]
|
Kirchhof, P., et al. (2012) Comprehensive Risk Reduction in Patients with Atrial Fibrillation: Emerging Diagnostic and Therapeutic Options: A Report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association Consensus Conference. Europace, 14, 8-27. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Swiryn, S., et al. (2016) Clinical Implications of Brief De-vice-Detected Atrial Tachyarrhythmias in a Cardiac Rhythm Management Device Population: Results from the Registry of Atrial Tachycardia and Atrial Fibrillation Episodes. Circulation, 134, 1130-1140. [Google Scholar] [CrossRef]
|
|
[34]
|
Glotzer, T.V., et al. (2009) The Relationship be-tween Daily Atrial Tachyarrhythmia Burden from Implantable Device Diagnostics and Stroke Risk: The TRENDS Study. Circulation: Arrhythmia and Electrophysiology, 2, 474-480. [Google Scholar] [CrossRef]
|
|
[35]
|
Van Gelder, I.C., et al. (2017) Duration of Device-Detected Subclinical Atrial Fibrillation and Occurrence of Stroke in ASSERT. European Heart Journal, 38, 1339-1344. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Glotzer, T.V., et al. (2003) Atrial High Rate Episodes Detected by Pacemaker Diagnostics Predict Death and Stroke: Report of the Atrial Diagnostics Ancillary Study of the MOde Selec-tion Trial (MOST). Circulation, 107, 1614-1619. [Google Scholar] [CrossRef]
|
|
[37]
|
Sanna, T., et al. (2014) Cryptogenic Stroke and Un-derlying Atrial Fibrillation. The New England Journal of Medicine, 370, 2478-2486. [Google Scholar] [CrossRef]
|
|
[38]
|
Boriani, G., et al. (2014) Device-Detected Atrial Fibrillation and Risk for Stroke: An Analysis of >10,000 Patients from the SOS AF Project (Stroke Prevention Strategies Based on Atrial Fibrillation Information from Implanted Devices). European Heart Journal, 35, 508-516. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Botto, G.L., et al. (2009) Presence and Duration of Atrial Fibrillation Detected by Continuous Monitoring: Crucial Implications for the Risk of Thromboembolic Events. Journal of Cardiovascular Electrophysiology, 20, 241-248. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Tayal, A.H., et al. (2008) Atrial Fibrillation Detected by Mobile Cardiac Outpatient Telemetry in Cryptogenic TIA or Stroke. Neurology, 71, 1696-1701. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Jabaudon, D., et al. (2004) Usefulness of Ambulatory 7-Day ECG Monitoring for the Detection of Atrial Fibrillation and Flutter after Acute Stroke and Transient Ischemic Attack. Stroke, 35, 1647-1651. [Google Scholar] [CrossRef]
|
|
[42]
|
Zhao, S.X., et al. (2019) Evaluation of a Clinical Score for Predicting Atrial Fibrillation in Cryptogenic Stroke Patients with Insertable Cardiac Monitors: Results from the CRYSTAL AF Study. Therapeutic Advances in Neurological Disorders, 12, 1756286419842698. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Gladstone, D.J., et al. (2015) Atrial Premature Beats Predict Atrial Fibrillation in Cryptogenic Stroke: Results from the EMBRACE Trial. Stroke, 46, 936-941. [Google Scholar] [CrossRef]
|
|
[44]
|
Sieweke, J.T., et al. (2020) Septal Total Atrial Conduction Time for Prediction of Atrial Fibrillation in Embolic Stroke of Unknown Source: A Pilot Study. Clinical Research in Cardiology, 109, 205-214. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Perino, A.C., et al. (2019) Practice Variation in Anticoagulation Prescription and Outcomes after Device-Detected Atrial Fibrillation. Circulation, 139, 2502-2512. [Google Scholar] [CrossRef]
|
|
[46]
|
Hess, P.L., et al. (2017) The Role of Cardiovas-cular Implantable Electronic Devices in the Detection and Treatment of Subclinical Atrial Fibrillation: A Review. JAMA Cardiology, 2, 324-331. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Gorenek, B.C., et al. (2017) Device-Detected Subclinical Atrial Tachyarrhythmias: Definition, Implications and Management: An European Heart Rhythm Association (EHRA) Consensus Document, Endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE). Europace, 19, 1556-1578. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Clinicaltrials.gov. Apixaban for the Reduction of Thrombo-Embolism in Patients with Device-Detected Subclinical Atrial Fibrillation (ARTESiA). NCT01938248.
https://clinicaltrials.gov/ct2/show/NCT01938248
|
|
[49]
|
Clinicaltrials.gov. Non-Vitamin K Antagonist Oral Anti-coagulants in Patients with Atrial High Rate Episodes (NOAH). NCT02618577.
https://clinicaltrials.gov/ct2/show/NCT02618577
|
|
[50]
|
Lopes, R.D., et al. (2017) Rationale and Design of the Apixaban for the Reduction of Thrombo-Embolism in Patients with Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) Trial. American Heart Journal, 189, 137-145. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Kirchhof, P., et al. (2017) Probing Oral Anticoagulation in Patients with Atrial High Rate Episodes: Rationale and Design of the Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial High Rate Episodes (NOAH-AFNET 6) Trial. American Heart Journal, 190, 12-18. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Vermond, R.A., et al. (2015) Incidence of Atrial Fibrillation and Relationship with Cardiovascular Events, Heart Failure, and Mortality: A Community-Based Study from the Netherlands. Journal of the American College of Cardiology, 66, 1000-1007. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Ellis, E.R. and Josephson, M.E. (2013) Heart Failure and Tach-ycardia-Induced Cardiomyopathy. Current Heart Failure Reports, 10, 296-306. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Linssen, G.C., et al. (2011) Clinical and Prognostic Effects of Atrial Fibrillation in Heart Failure Patients with Reduced and Preserved Left Ventricular Ejection Fraction. European Journal of Heart Failure, 13, 1111-1120. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Phan, T.T., et al. (2009) Increased Atrial Contribution to Left Ventricular Filling Compensates for Impaired Early Filling during Exercise in Heart Failure with Preserved Ejection Fraction. Journal of Cardiac Failure, 15, 890-897. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Taillandier, S., et al. (2014) Prognosis in Patients Hospitalized with Permanent and Nonpermanent Atrial Fibrillation in Heart Failure. American Journal of Cardiology, 113, 1189-1195. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Everett, T.H. and Olgin, J.E. (2007) Atrial Fibrosis and the Mechanisms of Atrial Fibrillation. Heart Rhythm Journal, 4, S24-S27. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Westermann, D., et al. (2011) Cardiac Inflammation Contributes to Changes in the Extracellular Matrix in Patients with Heart Failure and Normal Ejection Fraction. Circulation: Heart Failure, 4, 44-52. [Google Scholar] [CrossRef]
|
|
[59]
|
Ling, L.H., et al. (2012) Irregular Rhythm Ad-versely Influences Calcium Handling in Ventricular Myocardium: Implications for the Interaction between Heart Failure and Atrial Fibrillation. Circulation: Heart Failure, 5, 786-793. [Google Scholar] [CrossRef]
|
|
[60]
|
Glotzer, T.V. (2018) The Cacophony of Silent Atrial Fibrillation. Journal of the American College of Cardiology, 71, 2612-2615. [Google Scholar] [CrossRef] [PubMed]
|
|
[61]
|
Healey, J.S., et al. (2016) Occurrence of Death and Stroke in Pa-tients in 47 Countries 1 Year after Presenting with Atrial Fibrillation: A Cohort Study. The Lancet, 388, 1161-1169. [Google Scholar] [CrossRef]
|
|
[62]
|
Fauchier, L., et al. (2016) Causes of Death and Influencing Factors in Patients with Atrial Fibrillation. The American Journal of Medicine, 129, 1278-1287. [Google Scholar] [CrossRef] [PubMed]
|
|
[63]
|
Marijon, E., et al. (2013) Causes of Death and Influencing Factors in Patients with Atrial Fibrillation: A Competing-Risk Analysis from the Randomized Evaluation of Long-Term Anticoagulant Therapy Study. Circulation, 128, 2192-2201. [Google Scholar] [CrossRef]
|
|
[64]
|
Yang, H., et al. (2015) Clinical Prediction of In-cident Heart Failure Risk: A Systematic Review and Meta-Analysis. Open Heart, 2, e000222. [Google Scholar] [CrossRef] [PubMed]
|
|
[65]
|
Stewart, S., et al. (2002) A Population-Based Study of the Long-Term Risks Associated with Atrial Fibrillation: 20-Year Follow-up of the Renfrew/Paisley Study. The American Journal of Medicine, 113, 359-364. [Google Scholar] [CrossRef]
|
|
[66]
|
Ohsawa, M., et al. (2017) Risk of Stroke and Heart Failure Attributable to Atrial Fibrillation in Middle-Aged and Elderly People: Results from a Five-Year Prospective Cohort Study of Japanese Community Dwellers. Journal of Epidemiology, 27, 360-367. [Google Scholar] [CrossRef] [PubMed]
|
|
[67]
|
Wong, J.A., et al. (2018) Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure. Journal of the American College of Cardiology, 71, 2603-2611. [Google Scholar] [CrossRef] [PubMed]
|